Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...
FORT WORTH, Texas, April 06, 2026--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of Clareon® ...
“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...
Clareon PanOptix, which delivers exceptional clarity and offers spectacle independence across all distances with a patient satisfaction rate of 99.2%31-34; PanOptix® Trifocal IOL, implanted over 2.2 ...
Alcon and RxSight have announced a $200 million collaboration to develop post-operative adjustable presbyopic correction intraocular lenses (PCIOLs), marking a strategic pivot for Alcon after years of ...
Please provide your email address to receive an email when new articles are posted on . The lens will combine light-adjustable technology from RxSight with optical designs from Alcon. RxSight will ...
PanOptix delivers outstanding patient satisfaction and freedom from glasses; Vivity has a proven exceptionally low rate of visual disturbances2-8,**,Δ,§,^,‡ Alcon is committed to furthering innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results